Kö'ln, Germany

Bodo Ortmann



Average Co-Inventor Count = 15.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2008-2011

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Bodo Ortmann: Innovator in Modular Transfection Systems

Introduction

Bodo Ortmann is a notable inventor based in Köln, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of modular transfection systems. With a total of two patents to his name, Ortmann's work focuses on innovative methods for cell transfection.

Latest Patents

Ortmann's latest patents revolve around a method for transfection of cells using proteins capable of forming nucleoprotein filaments. The process involves modifying the protein with functional components that influence various steps of transfection. The nucleic acid intended for transfection is loaded with the modified protein, resulting in a filament-like complex. This complex is then introduced to the target cells. His inventions also include a transfection agent consisting of nucleoprotein filaments, which can be utilized for gene therapeutic treatments in humans and animals. Additionally, these inventions encompass pharmaceutical preparations for gene therapy and the use of transfection agents in kits.

Career Highlights

Throughout his career, Bodo Ortmann has worked with prominent companies in the biotechnology sector, including Lonza Cologne GmbH and Amaxa AG. His experience in these organizations has contributed to his expertise in the field of transfection technologies.

Collaborations

Ortmann has collaborated with notable colleagues such as Hanns-Martin Schmidt and Ludger Altrogge. These partnerships have further enriched his work and innovations in biotechnology.

Conclusion

Bodo Ortmann's contributions to modular transfection systems highlight his role as a key innovator in biotechnology. His patents and collaborations reflect a commitment to advancing gene therapy techniques.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…